Atherogenics' Unattributed VC - II Round

Atherogenics raised a round of funding on June 25, 2001.

AtheroGenics is an emerging pharmaceutical company, focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as heart disease…

Articles about Atherogenics' Unattributed VC - II Round: